Furthermore, Alizadeh et al. reported potential immune modulatory effects of anthracycline by demonstrating that doxorubicin eliminated myeloid-derived suppressor cells and increased CD4 + and CD8 + T cells using a breast cancer mouse model [15, 34, 35]. Here, CD8A is linked to breast carcinoma.